TR200101082T2 - Bilinci veya algılama yeteneğini geliştirici bileşimler. - Google Patents

Bilinci veya algılama yeteneğini geliştirici bileşimler.

Info

Publication number: TR200101082T2
Authority: TR; Turkey
Prior art keywords: active ingredient; perception; alzheimer; disease; compositions
Prior art date: 1998-10-16

Application number

TR2001/01082T

Other languages

English (en)

Turkish (tr)

Inventor

Leonce Irma De Nijs Paul

Louis Julien Parys Wim

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-12

Publication date

2001-09-21

1999-10-12 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2001-09-21 Publication of TR200101082T2 publication Critical patent/TR200101082T2/xx

Links

230000008447 perception Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 4
208000024827 Alzheimer disease Diseases 0.000 abstract 2
206010012289 Dementia Diseases 0.000 abstract 2
230000009286 beneficial effect Effects 0.000 abstract 2
229940100578 Acetylcholinesterase inhibitor Drugs 0.000 abstract 1
208000028017 Psychotic disease Diseases 0.000 abstract 1
239000000164 antipsychotic agent Substances 0.000 abstract 1
239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
230000001627 detrimental effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000006870 function Effects 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

TR2001/01082T 1998-10-16 1999-10-12 Bilinci veya algılama yeteneğini geliştirici bileşimler. TR200101082T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98203454		1998-10-16

Publications (1)

Publication Number	Publication Date
TR200101082T2 true TR200101082T2 (tr)	2001-09-21

Family

ID=8234219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2001/01082T TR200101082T2 (tr)	1998-10-16	1999-10-12	Bilinci veya algılama yeteneğini geliştirici bileşimler.

Country Status (20)

Country	Link
EP (1)	EP1121131A2 (id)
JP (1)	JP2002527469A (id)
KR (1)	KR20010072878A (id)
CN (1)	CN1367697A (id)
AU (1)	AU6472799A (id)
BG (1)	BG105302A (id)
BR (1)	BR9914419A (id)
CA (1)	CA2345767A1 (id)
EE (1)	EE200100136A (id)
HK (1)	HK1039745A1 (id)
HR (1)	HRP20010262A2 (id)
HU (1)	HUP0103781A3 (id)
ID (1)	ID28441A (id)
IL (1)	IL142588A0 (id)
NO (1)	NO20011403L (id)
PL (1)	PL348107A1 (id)
SK (1)	SK4592001A3 (id)
TR (1)	TR200101082T2 (id)
WO (1)	WO2000023057A2 (id)
ZA (1)	ZA200103081B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0102841D0 (en) *	2001-02-05	2001-03-21	Novartis Ag	Organic compounds
AU2006201188B2 (en) *	2001-02-05	2007-11-15	Novartis Ag	New use of iloperidone
BRPI0213564B8 (pt)	2001-10-30	2021-05-25	Novartis Ag	formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula
GB0216416D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
US20040192754A1 (en) *	2003-03-24	2004-09-30	Shapira Nathan Andrew	Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) *	2003-04-01	2005-01-16	Novartis Ag	Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2006065233A1 (en) *	2004-12-10	2006-06-22	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
WO2005065645A2 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Donepezil formulations
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
ATE554085T1 (de)	2006-11-30	2012-05-15	Probiodrug Ag	Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja)	2007-03-01	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (en)	2007-04-18	2014-12-24	Probiodrug AG	Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (es) *	2007-07-16	2009-02-25	World Trade Imp Export Wtie Ag	Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
AU2011215870B2 (en)	2010-02-09	2016-01-28	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6026284B2 (ja)	2010-03-03	2016-11-16	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤
NZ602312A (en)	2010-03-10	2014-02-28	Probiodrug Ag	Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
EP2686313B1 (en)	2011-03-16	2016-02-03	Probiodrug AG	Benzimidazole derivatives as inhibitors of glutaminyl cyclase
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6433482B2 (ja)	2013-03-15	2018-12-05	エージンバイオ，インコーポレイテッド	認知機能を改善するための方法および組成物
WO2016191288A1 (en)	2015-05-22	2016-12-01	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
WO1992020327A1 (en) *	1991-05-14	1992-11-26	Ernir Snorrason	Treatment of fatigue syndrome with cholinesterase inhibitors
JP4640888B2 (ja) *	1997-08-11	2011-03-02	ザユニヴァーシティーオブサウスフロリダ	神経精神性疾患用ニコチンアンタゴニスト
EP1073432B1 (en) *	1998-04-14	2007-08-15	The General Hospital Corporation	Use of d-serine or d-alanine for treating schizophrenia

1999
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Withdrawn
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/zh unknown
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown

Also Published As

Publication number	Publication date
WO2000023057A3 (en)	2000-07-27
HRP20010262A2 (en)	2002-06-30
HUP0103781A2 (hu)	2002-03-28
HK1039745A1 (zh)	2002-05-10
NO20011403D0 (no)	2001-03-20
CN1367697A (zh)	2002-09-04
WO2000023057A2 (en)	2000-04-27
HUP0103781A3 (en)	2003-09-29
AU6472799A (en)	2000-05-08
CA2345767A1 (en)	2000-04-27
BR9914419A (pt)	2001-06-26
NO20011403L (no)	2001-03-20
EP1121131A2 (en)	2001-08-08
SK4592001A3 (en)	2001-12-03
BG105302A (en)	2001-11-30
KR20010072878A (ko)	2001-07-31
IL142588A0 (en)	2002-03-10
PL348107A1 (en)	2002-05-06
ID28441A (id)	2001-05-24
ZA200103081B (en)	2002-07-12
JP2002527469A (ja)	2002-08-27
EE200100136A (et)	2002-06-17

Publication	Publication Date	Title
TR200101082T2 (tr)	2001-09-21	Bilinci veya algılama yeteneğini geliştirici bileşimler.
TR199700190A2 (xx)	1997-10-21	Uzat�lm�� z�lme form�l�.
EP1040830A4 (en)	2002-10-23	MEDICINE FOR NEURODEGENERATIVE DISEASES
ATE129500T1 (de)	1995-11-15	Neuartige antiepileptika.
TR200100172T2 (tr)	2001-05-21	Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
ES2178036T3 (es)	2002-12-16	Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
MX9701946A (es)	1998-04-30	Solucion oftalmica transportadora.
ATE211384T1 (de)	2002-01-15	Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE147981T1 (de)	1997-02-15	Verabreichung von lamotrigin zur behandlung von neuro-aids
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
TR199700878T1 (xx)	1998-01-21	Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
TR200003736T2 (tr)	2001-06-21	Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
TR200200449T2 (tr)	2002-08-21	Klonidin içeren etken madde kombinasyonu
EA199900876A1 (ru)	2000-04-24	Фармацевтические композиции против кашля
SE8103369L (sv)	1981-11-28	Antiperspirantkomposition innehallande en aluminiumklorid och en aluminiumzirkoniumhydroxiklorid som aktiva bestandsdelar och sett att inhibera perspiration
NZ319138A (en)	1999-11-29	Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
DE60132008D1 (de)	2008-01-31	Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
MXPA03000606A (es)	2004-04-02	Derivados de benzofurano y su uso como agentes antibacterianos.
TR199700858A2 (xx)	1998-03-21	Alzheimer hastal��n�n tedavisine y�nelik ispen�iyari bile�imler.
YU25001A (sh)	2004-07-15	Optički aktivan derivat piridil-4h-1,2,4-oksadiazina i njegova upotreba u proizvodnji lekova za tretiranje vaskularnih bolesti
DK0917460T3 (da)	2002-03-25	Cyclosporin-formulering
ATE309803T1 (de)	2005-12-15	Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
LT96094A (en)	1996-12-27	The active ingredient of pharmaceutical composition for treating constipation
FR2710844B1 (fr)	1995-12-29	Composition pour le traitement ou la prévention de l'herpès.
DK0805817T3 (da)	2001-11-26	Thiolderivater med metallopeptidaseinhiberende aktivitet